PDR
MCID: PRL007
MIFTS: 54

Proliferative Diabetic Retinopathy (PDR) malady

Summaries for Proliferative Diabetic Retinopathy

Sources:
33MalaCards
See all sources

Fully expand this MalaCard

Export this MalaCard
MalaCards: Proliferative Diabetic Retinopathy, also known as pigmentary disorder, reticulate, with systemic manifestations, is related to proliferative vitreoretinopathy and diabetic macular edema. An important gene associated with Proliferative Diabetic Retinopathy is SERPINF1 (serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1), and among its related pathways are Rho Family GTPases and Akt Signaling. The compounds vegf and tyrosine have been mentioned in the context of this disorder. Affiliated tissues include retina, placenta and monocytes, and related mouse phenotypes are immune system and cardiovascular system.

Aliases & Classifications for Proliferative Diabetic Retinopathy

Sources:
8Disease Ontology, 10DISEASES, 45Novoseek, 61UMLS, 57SNOMED-CT, 27ICD9CM, 40NCIt
See all sources

Aliases & Descriptions:

proliferative diabetic retinopathy 8 10 45 61
pigmentary disorder, reticulate, with systemic manifestations 61
pdr 8


External Ids:

Disease Ontology8 DOID:13207
ICD9CM27 362.02
SNOMED-CT57 154679002, 59276001
NCIt40 C84457

Related Diseases for Proliferative Diabetic Retinopathy

Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases related to Proliferative Diabetic Retinopathy via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 220)
idRelated DiseaseScoreTop Affiliating Genes
1proliferative vitreoretinopathy31.2TGFB2
2diabetic macular edema31.1SERPINF1, VEGFA
3neovascular glaucoma30.8VEGFA
4diabetic nephropathy30.6ADM, SERPINF1, MIF, CTGF, CCL2, TIMP3
5osteoarthritis30.3TGFB2, VCAM1, CXCL12, CXCL10, ANGPT2, CTGF
6uveitis30.3TGFB2, SERPINF1, CXCL10, CCL2
7blindness30.3SERPINF1, VEGFA, TIMP3
8type 1 diabetes30.3CXCL10, IGFBP1, SST, GAD1
9coronary artery disease,30.2VTN, VCAM1, IGFBP1, CCL2
10background diabetic retinopathy10.4
11severe nonproliferative diabetic retinopathy10.4
12vitreous detachment10.4
13diabetic cataract10.4
14hypoxia10.4
15somatostatin analog10.4
16acromegaly10.3
17rubeosis iridis10.3
18sleep disorder10.3
19vitreous disease10.3
20eales disease10.3
21paragonimiasis10.2
22amyloidosis10.2
23pigment disorder, reticulate10.2
24ischemic retinopathy10.2
25carotid stenosis10.2
26retinal ischemia10.2
27retinitis pigmentosa10.2
28hemochromatosis10.2
29gestational diabetes10.2
30young syndrome10.2
31cytomegalovirus retinitis10.2
32diabetes, type 210.2
33homocysteine plasma level10.2
34autosomal dominant neovascular inflammatory vitreoretinopathy10.2
35japanese encephalitis10.1
36opisthorchiasis10.1
37x-linked reticulate pigmentary disorder with systemic manifestations10.1
38adenocarcinoma10.0TGFB2, ADM, VTN, SERPINF1, CXCL12, CXCL10
39melanoma10.0TGFB2, VTN, SERPINF1, VCAM1, CXCL10, ANGPT2
40prostate cancer10.0TGFB2, SERPINF1, CXCL12, CXCL10, EPHB4, MIF
41rheumatoid arthritis10.0VTN, VCAM1, CXCL12, CXCL10, MIF, ANGPT2
42hepatocellular carcinoma10.0TGFB2, VTN, SERPINF1, CXCL12, EPHB4, ANGPT2
43diabetic retinopathy10.0TGFB2, ADM, VTN, SERPINF1, VCAM1, CXCL12
44squamous cell carcinoma10.0TGFB2, ADM, VTN, SERPINF1, CXCL12, EPHB4
45atherosclerosis10.0VTN, SERPINF1, VCAM1, CXCL12, CXCL10, MIF
46asthma10.0ADM, VTN, VCAM1, PTGDS, CXCL12, CXCL10
47ischemia10.0TGFB2, ADM, VTN, CXCL12, EPHB4, ANGPT2
48retinal disease10.0ADM, SERPINF1, VCAM1, EPHB4, IGFBP1, ANGPT2
49multiple sclerosis10.0VTN, VCAM1, PTGDS, CXCL12, CXCL10, MIF
50astrocytoma10.0TGFB2, VTN, VCAM1, CXCL10, ANGPT2, VEGFA

Graphical network of the top 20 diseases related to Proliferative Diabetic Retinopathy:



Diseases related to proliferative diabetic retinopathy

Clinical Features for Proliferative Diabetic Retinopathy

Drugs & Therapeutics for Proliferative Diabetic Retinopathy

Sources:
5CenterWatch, 42NIH Clinical Center, 6ClinicalTrials, 61UMLS, 41NDF-RT
See all sources

Approved drugs:

Search CenterWatch for Proliferative Diabetic Retinopathy

Drug clinical trials:

Search ClinicalTrials for Proliferative Diabetic Retinopathy

Search NIH Clinical Center for Proliferative Diabetic Retinopathy

Search CenterWatch for Proliferative Diabetic Retinopathy

Genetic Tests for Proliferative Diabetic Retinopathy

Anatomical Context for Proliferative Diabetic Retinopathy

Sources:
33MalaCards
See all sources

MalaCards organs/tissues related to Proliferative Diabetic Retinopathy:

33
Retina, Placenta, Monocytes, T cells, B cells, Endothelial, Tongue

Animal Models for Proliferative Diabetic Retinopathy or affiliated genes

Sources:
37MGI, 28inGenious Targeting Laboratory
See all sources

Publications for Proliferative Diabetic Retinopathy

Sources:
51PubMed
See all sources

Articles related to Proliferative Diabetic Retinopathy:

(show top 50)    (show all 563)
idTitleAuthorsYear
1
Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy. (23370902)
2013
2
Expression of thrombospondin-2 as a marker in proliferative diabetic retinopathy. (23387388)
2013
3
Influence of preoperative intravitreal bevacizumab on visual function in eyes with proliferative diabetic retinopathy. (23038607)
2013
4
Angiogenesis regulatory factors in the vitreous from patients with proliferative diabetic retinopathy. (21947384)
2013
5
Feedback of personal retinal images appears to have a motivational impact in people with non-proliferative diabetic retinopathy and suboptimal HbA1c: findings of a pilot study. (23601012)
2013
6
Cysteine-rich 61 (CYR61) is up-regulated in proliferative diabetic retinopathy. (22160564)
2012
7
Plasma, aqueous and vitreous homocysteine levels in proliferative diabetic retinopathy. (22353698)
2012
8
Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy. (22457045)
2012
9
Re: Single session of Pascal versus multiple sessions of conventional laser for panretinal photocoagulation in proliferative diabetic retinopathy: a comparative study. (22922853)
2012
10
Intraocular VEGF level as a risk factor for postoperative complications after vitrectomy for proliferative diabetic retinopathy. (22899753)
2012
11
Intravitreal bevacizumab increases intraocular interleukin-6 levels at 1 day after injection in patients with proliferative diabetic retinopathy. (22846147)
2012
12
High-mobility group box-1 and endothelial cell angiogenic markers in the vitreous from patients with proliferative diabetic retinopathy. (23118492)
2012
13
Ophthalmodynamometric pressure in eyes with proliferative diabetic retinopathy measured during pars plana vitrectomy. (21236404)
2011
14
Retro-mode imaging of fibrovascular membrane in proliferative diabetic retinopathy after intravitreal bevacizumab injection. (21760719)
2011
15
Increased IL-6 levels are not related to NF-I_B or HIF-1I+ transcription factors activity in the vitreous of proliferative diabetic retinopathy. (21813290)
2011
16
The role of SLIT-ROBO signaling in proliferative diabetic retinopathy and retinal pigment epithelial cells. (21686327)
2011
17
Treatment of proliferative diabetic retinopathy with anti-VEGF agents. (21294854)
2011
18
Alteration of melatonin secretion in patients with type 2 diabetes and proliferative diabetic retinopathy. (21629571)
2011
19
Antiangiogenic drugs and advanced proliferative diabetic retinopathy. (21779675)
2011
20
Comparison of clinical outcomes between 23-gauge and 20-gauge vitrectomy in patients with proliferative diabetic retinopathy. (20661174)
2010
21
LSFG findings of proliferative diabetic retinopathy after intravitreal injection of bevacizumab. (21117574)
2010
22
Vascular endothelial growth factor-A (VEGF-A) in vitreous fluid of patients with proliferative diabetic retinopathy. (20214050)
2009
23
Intravitreal pegaptanib in severe proliferative diabetic retinopathy leading to the progression of tractional retinal detachment. (18551139)
2009
24
Genetic variation and plasma level of the basic fibroblast growth factor in proliferative diabetic retinopathy. (17997184)
2008
25
Retinal detachment with macular hole following intravitreal bevacizumab in patient with severe proliferative diabetic retinopathy. (18441183)
2008
26
Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy. (18682813)
2008
27
Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy. (17380318)
2007
28
Comparison of vitrectomy alone and combined vitrectomy, phacoemulsification and intraocular lens implantation for proliferative diabetic retinopathy. (17606428)
2007
29
Glial cell line-derived neurotrophic factor in the vitreous of patients with proliferative diabetic retinopathy. (16186306)
2005
30
Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy. (16123502)
2005
31
Impaired coronary collateral vessel development in patients with proliferative diabetic retinopathy. (16144215)
2005
32
Elevated serum levels of N(epsilon)-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema. (15258735)
2004
33
Diverse NF-kappaB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy. (14737065)
2004
34
Incidence of proliferative retinopathy and sex-related differences in death rate among patients with diabetes mellitus and sight impairment treated with insulin (according to the data from national diabetic registry)]. (15724607)
2004
35
Retinal outcomes in proliferative diabetic retinopathy presenting during and after pregnancy. (15605908)
2004
36
Levels of human tissue kallikrein in the vitreous fluid of patients with severe proliferative diabetic retinopathy. (15258415)
2004
37
Interleukin-8, nitric oxide and glutathione status in proliferative vitreoretinopathy and proliferative diabetic retinopathy. (12920337)
2003
38
Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy. (12841570)
2003
39
Renin-angiotensin system in proliferative diabetic retinopathy and its gene expression in cultured human mA1ller cells. (12586176)
2003
40
Optical coherence tomography of tractional macular elevations in eyes with proliferative diabetic retinopathy. (11438058)
2001
41
Ipsilateral proliferative diabetic retinopathy in carotid stenosis. (11318273)
2001
42
Vitreous levels of insulin-like growth factor-I in patients with proliferative diabetic retinopathy. (11910526)
2001
43
Light panretinal photocoagulation (LPRP) versus classic panretinal photocoagulation (CPRP) in proliferative diabetic retinopathy. (15487693)
2001
44
Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study. (11289478)
2001
45
Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy. (10845581)
2000
46
Fluorescein angiography of extreme peripheral retina and rubeosis iridis in proliferative diabetic retinopathy. (10458295)
1999
47
A comparative study of vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy]. (10451953)
1997
48
Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. (8814750)
1996
49
Protein composition of the vitreous body in proliferative diabetic retinopathy. An analysis with 2-D-electrophoresis]. (7849428)
1994
50
Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. (1693499)
1990

Genetic Variations for Proliferative Diabetic Retinopathy

Expression for genes affiliated with Proliferative Diabetic Retinopathy

Sources:
1BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Proliferative Diabetic Retinopathy

Search GEO for disease gene expression data for Proliferative Diabetic Retinopathy.

Pathways for genes affiliated with Proliferative Diabetic Retinopathy

Sources:
52QIAGEN, 54Reactome, 30KEGG, 38NCBI BioSystems Database, 12EMD Millipore, 4Cell Signaling Technology
See all sources

Pathways related to Proliferative Diabetic Retinopathy according to GeneCards/GeneDecks:

(show all 24)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Hide members
10.5TIMP2, TIMP3, HGF, CCL2, CTGF, ANGPT2
2
Hide members
10.5TIMP2, TIMP3, HGF, CCL2, CTGF, ANGPT2
3
Hide members
10.5CCL2, VEGFA, SST, CXCL10, CXCL12, VCAM1
4
Hide members
10.5TIMP2, TIMP3, HGF, CTGF, ANGPT2, CXCL10
5
Hide members
10.5TIMP2, TIMP3, HGF, CCL2, CTGF, ANGPT2
610.5TIMP3, HGF, VEGFA, VTN
7
Hide members
10.5HGF, ANGPT2, EPHB4, CXCL10, CXCL12, SERPINF1
8
Hide members
10.5TIMP2, TIMP3, HGF, CTGF, CXCL12, VTN
9
Hide members
10.5CCL2, CXCL10, CXCL12, VCAM1, VTN
10
Hide members
10.5TIMP2, TIMP3, HGF, CTGF, EPHB4, CXCL12
11
Hide members
10.5TIMP2, TIMP3, HGF, CTGF, CXCL12
12
Hide members
10.5TIMP2, TIMP3, HGF, CTGF, EPHB4, CXCL12
13
Hide members
10.5CTGF, HGF, TIMP3
14
Hide members
10.5EPHB4, CTGF, HGF, TIMP3
1510.5VEGFA, TIMP3, TIMP2
16
Cell adhesion ECM remodeling
Hide members
10.5VTN, TIMP3, TIMP2
1710.5TGFB2, ANGPT2, TIMP3, TIMP2
18
Hide members
10.5TIMP2, HGF, CTGF, EPHB4, CXCL12
1910.5VEGFA, IGFBP1, CXCL12, ADM
2010.5CCL2, CXCL10, CXCL12
21
Hide members
10.5VEGFA
2210.5TIMP3
23
Hide members
10.5EPHB4, TIMP3
24
Hide members
10.5IGFBP1, CCL2

Compounds for genes affiliated with Proliferative Diabetic Retinopathy

Sources:
45Novoseek, 24HMDB, 50PharmGKB, 29IUPHAR, 11DrugBank, 60Tocris Bioscience, 2BitterDB
See all sources

Compounds related to Proliferative Diabetic Retinopathy according to GeneCards/GeneDecks:

(show top 50)    (show all 135)
idCompoundScoreTop Affiliating Genes
1vegf4511.1CTGF, CCL2, HGF, TIMP3, TIMP2, TGFB2
2tyrosine4511.0TIMP2, CXCL10, VTN, MIF, SERPINF1, EPHB4
3retinoic acid45 2412.0MIF, IGFBP1, SST, ANGPT2, CTGF, HGF
4dexamethasone45 50 29 1114.0CXCL12, ANGPT2, VEGFA, CTGF, HGF, TIMP3
5genistein45 29 60 2 11 2416.0SST, VEGFA, CCL2, HGF, TIMP3, TIMP2
6calcium45 50 11 2414.0ANGPT2, GAD1, CTGF, CCL2, HGF, TIMP3
7glucose4511.0TIMP3, CTGF, GAD1, ANGPT2, SERPINF1, TIMP2
8phosphatidylinositol4511.0ADM, CCL2, TIMP3, HGF, CTGF, ANGPT2
9lipid4511.0CCL2, IGFBP1, MIF, CXCL12, CXCL10, ADM
10heparin45 29 11 2414.0CTGF, TIMP3, TIMP2, VEGFA, CXCL12, VCAM1
11ly2940024511.0CCL2, VEGFA, HGF, CTGF, VCAM1, CXCL12
12oxygen45 2412.0ANGPT2, HGF, TIMP2, TIMP3, CCL2, GAD1
13paraffin4511.0ADM, TGFB2, CCL2, VEGFA, ANGPT2, VCAM1
14thymidine45 2412.0TGFB2, TIMP2, HGF, CTGF, ANGPT2, IGFBP1
15cysteine4511.0ADM, VTN, SERPINF1, TGFB2, VCAM1, IGFBP1
16creatinine4511.0IGFBP1, CXCL10, PTGDS, TIMP2, GAD1, ANGPT2
17nitric oxide45 11 2413.0ANGPT2, CTGF, IGFBP1, MIF, CXCL10, VCAM1
18matrigel4511.0TGFB2, CXCL10, CXCL12, VTN
19pge24511.0VTN, SST, VEGFA
20cycloheximide4510.9PTGDS, CXCL12, CXCL10, HGF, IGFBP1
21wortmannin4510.9HGF, CXCL12, TIMP3, CCL2, ANGPT2, CXCL10
22herbimycin a45 6011.9MIF, CXCL12, IGFBP1, CCL2, HGF, VTN
23glycosaminoglycan4510.9TIMP2, TIMP3, CXCL10, CXCL12, TGFB2, VTN
24cholesterol45 29 11 2413.9VCAM1, ADM, VTN, PTGDS, TIMP2, CCL2
25lactate4510.9VCAM1, ADM, VTN, MIF, IGFBP1, SST
26ribonucleic acid4510.9IGFBP1, ANGPT2, TGFB2, CTGF, CCL2, TIMP3
27streptozotocin4510.9ADM, SERPINF1, GAD1, SST
28sb 20358045 6011.9CCL2, CTGF, VEGFA, MIF, CXCL12, TIMP2
29ccl445 2911.9CXCL12, CXCL10, CCL2, HGF
30hyaluronic acid45 2411.9TIMP2, VCAM1, HGF, VEGFA, TGFB2, VTN
31hydrocortisone45 2 60 1113.9ADM, IGFBP1
32arginine4510.9VTN, CCL2, GAD1, SST, VCAM1, HGF
33fibrinogen4510.8IGFBP1, ANGPT2, VCAM1, CTGF, CCL2, TIMP2
34tamoxifen45 50 29 1113.8VTN, CXCL12, IGFBP1, VCAM1
35pioglitazone45 50 29 1113.8CCL2, TIMP2, CTGF, VEGFA, IGFBP1, VCAM1
36prostacyclin4510.8VTN, VCAM1, VEGFA, CTGF, HGF, CCL2
37losartan45 50 29 1113.8TIMP2, ADM, VCAM1, CTGF, CCL2, HGF
38pd 98,0594510.8CXCL12, TIMP3, VCAM1, CTGF, VTN, HGF
39serine4510.8CCL2, CTGF, MIF, SERPINF1, VTN, TIMP2
405fluorouracil4510.7HGF, TIMP2, SST, CXCL12, TGFB2, VEGFA
41testosterone45 60 11 2413.7TIMP3, TGFB2, VCAM1, ADM, PTGDS, IGFBP1
42estradiol45 11 2412.7TIMP3, GAD1, TGFB2
43steroid4510.7IGFBP1, TGFB2, ADM, CXCL12, MIF, TIMP3
44n acetylcysteine4510.7VCAM1, VEGFA, CTGF, HGF, CCL2, SERPINF1
45cytochalasin d45 6011.6CTGF, CXCL12, VCAM1, VTN, CCL2, TIMP2
46tgf beta14510.6CCL2, CTGF, VCAM1, TGFB2, HGF, TIMP3
47cyclophosphamide45 50 1112.5SST, MIF, CXCL12, HGF
48glutamate4510.5GAD1
49norepinephrine45 11 2412.4ADM
50histamine45 29 2412.2CCL2, SST, HGF, PTGDS, VCAM1, ADM

GO Terms for genes affiliated with Proliferative Diabetic Retinopathy

Sources:
16Gene Ontology
See all sources

Cellular components related to Proliferative Diabetic Retinopathy according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1extracellular regionGO:00557610.7TIMP2, ADM, VTN, SERPINF1, PTGDS, CXCL12
2extracellular spaceGO:00561510.7TIMP2, HGF, TGFB2, ADM, VTN, SERPINF1
3cell surfaceGO:00998610.5TIMP2, VEGFA, MIF, EPHB4, VCAM1
4neuronal cell bodyGO:04302510.5TGFB2, SST, CCL2, TIMP2
5extracellular matrixGO:03101210.4TGFB2, VTN, SERPINF1, TIMP3
6platelet alpha granule lumenGO:03109310.2HGF, VEGFA, TGFB2

Biological processes related to Proliferative Diabetic Retinopathy according to GeneCards/GeneDecks:

(show all 20)
idNameGO IDScoreTop Affiliating Genes
1response to hypoxiaGO:00166610.9TGFB2, ADM, VCAM1, ANGPT2, VEGFA, CCL2
2angiogenesisGO:00152510.8CCL2, CTGF, VEGFA, ANGPT2, EPHB4, TGFB2
3organ regenerationGO:03110010.8HGF, CCL2, ANGPT2, ADM
4negative regulation of angiogenesisGO:01652510.8SERPINF1, CXCL10, ANGPT2, CCL2
5positive regulation of peptidyl-tyrosine phosphorylationGO:05073110.8HGF, VEGFA, MIF, VTN
6positive chemotaxisGO:05091810.8MIF, VEGFA, HGF
7agingGO:00756810.8TIMP2, CCL2, VCAM1, ADM
8response to amino acid stimulusGO:04320010.8CCL2, CTGF, SST
9response to drugGO:04249310.8TGFB2, SST, GAD1, CCL2, TIMP2
10heart morphogenesisGO:00300710.7VEGFA, EPHB4, TGFB2
11blood circulationGO:00801510.7ADM, CXCL12, CXCL10
12cell surface receptor signaling pathwayGO:00716610.7CXCL10, MIF, SST, CCL2
13response to woundingGO:00961110.7CTGF, ADM, TGFB2
14positive regulation of cell proliferationGO:00828410.7TGFB2, ADM, CXCL10, VEGFA, CTGF
15cell adhesionGO:00715510.6CCL2, EPHB4, CXCL12, VCAM1, VTN
16response to glucocorticoid stimulusGO:05138410.6ADM, PTGDS, CCL2
17positive regulation of angiogenesisGO:04576610.5ADM, ANGPT2, VEGFA
18cell-cell signalingGO:00726710.5SST, CXCL10, ADM, TGFB2
19platelet degranulationGO:00257610.4HGF, VEGFA, TGFB2
20signal transductionGO:00716510.2CCL2, ANGPT2, IGFBP1, CXCL10, CXCL12, ADM

Molecular functions related to Proliferative Diabetic Retinopathy according to GeneCards/GeneDecks:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1receptor bindingGO:00510210.7TGFB2, ADM, CXCL12, CXCL10, MIF, ANGPT2
2growth factor activityGO:00808310.6HGF, CTGF, VEGFA, CXCL12, TGFB2
3integrin bindingGO:00517810.6TIMP2, CTGF, VCAM1, VTN
4chemoattractant activityGO:04205610.5MIF, VEGFA, HGF
5metalloendopeptidase inhibitor activityGO:00819110.5TIMP3, TIMP2
6heparin bindingGO:00820110.4CCL2, CTGF, VEGFA, VTN
7chemokine activityGO:00800910.2CXCL12, CXCL10, CCL2

Products for genes affiliated with Proliferative Diabetic Retinopathy

  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Proliferative Diabetic Retinopathy

3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
29IUPHAR
30KEGG
35MeSH
36MESH via Orphanet
37MGI
40NCIt
41NDF-RT
44NINDS
45Novoseek
47OMIM
48OMIM via Orphanet
51PubMed
52QIAGEN
58SNOMED-CT via Orphanet
61UMLS
62UMLS via Orphanet